UA74095U - Препарат для лечения туберкулеза - Google Patents
Препарат для лечения туберкулезаInfo
- Publication number
- UA74095U UA74095U UAU201208962U UAU201208962U UA74095U UA 74095 U UA74095 U UA 74095U UA U201208962 U UAU201208962 U UA U201208962U UA U201208962 U UAU201208962 U UA U201208962U UA 74095 U UA74095 U UA 74095U
- Authority
- UA
- Ukraine
- Prior art keywords
- drug
- tuberculosis
- treatment
- medicine
- chemical
- Prior art date
Links
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Препарат для лечения туберкулеза относится к химико-фармацевтической промышленности и медицине. Новый состав препарата позволяет повысить температуру хранения препарата, что важно при его транспортировке и хранении.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA201208962 | 2012-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA74095U true UA74095U (ru) | 2012-10-10 |
Family
ID=56889302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201208962U UA74095U (ru) | 2012-07-20 | 2012-07-20 | Препарат для лечения туберкулеза |
Country Status (6)
Country | Link |
---|---|
AP (1) | AP2015008270A0 (ru) |
BR (1) | BR112015001275A2 (ru) |
EA (1) | EA025861B1 (ru) |
RU (1) | RU2648822C2 (ru) |
UA (1) | UA74095U (ru) |
WO (1) | WO2014014434A1 (ru) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
US20120122812A1 (en) * | 2009-05-28 | 2012-05-17 | Natalja Nikolaevna Derkach | Anti-aging agent |
-
2012
- 2012-07-20 UA UAU201208962U patent/UA74095U/ru unknown
-
2013
- 2013-07-22 WO PCT/UA2013/000079 patent/WO2014014434A1/ru active Application Filing
- 2013-07-22 RU RU2015106366A patent/RU2648822C2/ru not_active IP Right Cessation
- 2013-07-22 AP AP2015008270A patent/AP2015008270A0/xx unknown
- 2013-07-22 BR BR112015001275-2A patent/BR112015001275A2/pt not_active IP Right Cessation
- 2013-07-22 EA EA201590243A patent/EA025861B1/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA025861B1 (ru) | 2017-02-28 |
RU2648822C2 (ru) | 2018-03-28 |
RU2015106366A (ru) | 2016-09-10 |
EA201590243A1 (ru) | 2015-06-30 |
BR112015001275A2 (pt) | 2018-01-30 |
AP2015008270A0 (en) | 2015-02-28 |
WO2014014434A1 (ru) | 2014-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7190242A2 (es) | Moduladores del transporte nuclear y usos de los mismos | |
DK2925272T3 (da) | Lægemiddelopbevarings-, udleverings- og administrationssystem | |
IL238713A0 (en) | Self-regulating active pharmaceutical ingredient release | |
GB201512336D0 (en) | Blister pack for storage and sterilization of inside contained objects | |
PT2815769T (pt) | Fam19a5 para utilização no diagnóstico e tratamento de lesões do snc | |
IL233813B (en) | Tray system for displaying, storing and transporting bottles | |
HK1221215A1 (zh) | -炔基咪唑衍生物和含有其作為有效成分的藥物 | |
HK1205450A1 (en) | Medicine comprising combination of general anesthetic drug and hydrogen | |
UY34786A (es) | Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo | |
FR2997321B1 (fr) | Installation de stockage et de delivrance de boites de medicaments | |
CO7200262A2 (es) | Nueva dosificación y formulación | |
UY34931A (es) | ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?. | |
HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
AU201613322S (en) | A Compliance Monitor for a Medicament Inhaler | |
SI2874600T1 (sl) | Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu | |
GB201419374D0 (en) | Childproof storage and timing device for administration of medicine | |
SI2656843T1 (sl) | Estri bendamustina in povezane spojine ter njihova medicinska uporaba | |
HUP1600414A2 (hu) | Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény | |
UA74095U (ru) | Препарат для лечения туберкулеза | |
EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
HK1203955A1 (zh) | 反式- -癸烯酸衍生物及含有其的藥物 | |
UA74097U (ru) | Способ изготовления средства для лечения туберкулеза | |
UA75204U (ru) | Спазмолитический и седативный препарат в форме мягких желатиновых капсул | |
GEP20135874B (en) | Drug for tuberculosis (t.b.) | |
AU367396S (en) | A compliance monitor for a medicament inhaler |